[NIH SACGHS Webcasts]
[15june2004]
[14june2004]
[1 March 2004]
[2 March 2004]
[23 Oct 2003]
[22 Oct 2003]
[11 June 2003]
[12 June 2003]

Secretary's Advisory Committee on Genetics, Health, and Society

Third Meeting
March 1-2, 2004
Washington, DC

D R A F T  A G E N D A

Monday, March 1, 2004

Opening Remarks

8:30 a.m. - 8:35 a.m.  Edward R.B. McCabe, M.D., Ph.D.

   SACGHS Chair

• Report of the SACGHS Task Force
   
• 8:35 a.m. – 9:00 a.m. Review of Inter-Meeting Task Force Process, Results of Priority Setting Process, and a Proposed Framework for the Committee's Priority Setting Process
• Emily Winn-Deen, Ph.D.
• Chair, Intra-Meeting Task Force
   
• 9:00 a.m. – 10:30 a.m. Presentation of Background Information
• Task Force Chair and/or Members
   
• 10:30 a.m. – 10:45 a.m. BREAK
   

Discussion of the Issues

 

• 10:45 p.m. – 12:30 p.m. Committee Discussion
• 12:30 p.m. – 1:30 p.m. Working Lunch
   

Public Comment Session

1:30 p.m. – 2:00 p.m.  Members of the Public

• Coverage and Reimbursement for Genetic Services and Technologies
   
• 2:00 p.m. – 2:30 p.m. Medicare Coverage of Genetic Technologies and Coverage Decision-making Process
• Sean Tunis, M.D., M.Sc.
   Chief Medical Officer
   Centers for Medicare & Medicaid Services
   Medicare Payment Rates and Rate-setting Process for Genetic Technologies
• TBD
   
• 2:30 p.m. – 2:50 p.m. Coverage and Reimbursement Decision-making Process for Genetic Technologies by Private Health Plans
• Michele Schoonmaker, Ph.D. (invited)
• Congressional Research Service
  
  2:50 p.m. –3:05 p.m. BREAK

3:05 p.m.– 3:25 p.m.   Issues in the Reimbursement of Genetic Tests

• Andrea Ferreira-Gonzalez, Ph.D.
  Associate Professor and Director, Molecular Diagnostics Lab
  Division of Molecular Diagnostics, Department of Pathology
  Virginia Commonwealth University

3:25 p.m. – 3:45 p.m.  Issues in the Reimbursement of Genetic Services

• Marc Williams, M.D. (invited)
• Gundersen Lutheran Medical Center
  
  3:45 p.m. – 4:05 p.m. Economic Modeling: Coverage and Reimbursement of Genetic Services and Technologies and the Impact on the Health Care System
• Ronald Bachman, M.D.
   Chief, Genetics Department
   Kaiser Permanente of Northern California
   
• 4:05 p.m. – 4:25 p.m. Cost-Effectiveness of Genetic Technologies
  David Veenstra, Pharm.D., Ph.D. (invited)\
  ProfessorDepartment of Clinical Pharmacy
  University of California, San Francisco School of Pharmacy
   
• 4:25 p.m. - 5:30 p.m.                  Roundtable Discussion